Showing results (91-100 of 198) with videos related to
Sort By:
Pageof 20
Cancer|January 15, 2014
Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysisBeth M Beadle, Kai-Ping Liao, Linda S Elting, et al.Cancer Research|December 25, 2002
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinomaK Kian Ang, Brian A Berkey, Xiaoyu Tu, et al.International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancerSue S Yom, William H Morrison, K Kian Ang, et al.International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility studyBénédicte Comet, Andrew Kramar, Mathieu Faivre-Pierret, et al.International Journal of Radiation Oncology, Biology, Physics|November 18, 2005
Molecular signatures associated with clinical outcome in patients with high-risk head-and-neck squamous cell carcinoma treated by surgery and radiationUma Giri, Cheryl L Ashorn, Latha Ramdas, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2009
Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Melanie White-Koning, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Adil Benlyazid, et al.Cancer Research|November 20, 2002
Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinomaKhaled A Hassan, K Kian Ang, Adel K El-Naggar, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 27, 2012
Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathwaysUma Raju, Oliver Riesterer, Zhi-Qiang Wang, et al.International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatmentIan J Bristol, Anesa Ahamad, Adam S Garden, et al.Pageof 20